Gyeonggi-do, South Korea

Jung Eun Park

USPTO Granted Patents = 1 

Average Co-Inventor Count = 19.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Genius of Jung Eun Park

Introduction

Jung Eun Park is a remarkable inventor based in Gyeonggi-do, South Korea, known for her significant contributions to the field of pharmaceuticals. With a strong passion for innovation, she focuses on developing novel compounds that can enhance healthcare outcomes.

Latest Patents

Jung Eun Park holds one patent, titled "Acid secretion inhibitor and use thereof." This invention presents a novel compound referred to by Chemical Formula 2, or a pharmaceutically acceptable salt. The innovative compound exhibits an excellent inhibitory effect on acid secretion, highlighting her capability to contribute meaningfully to medical advancements.

Career Highlights

Jung Eun Park has made notable strides in her career while working at Il Dong Pharmaceutical Co., Ltd. Her dedication to research and development has allowed her to make value-added contributions in her field. The patented compound embodies her commitment to innovation in pharmaceuticals, showing her potential to influence the industry positively.

Collaborations

Throughout her career, Jung Eun Park has collaborated with talented professionals, including her coworkers Hong Chul Yoon and Joon Tae Park. These collaborations emphasize the importance of teamwork in achieving meaningful innovations and advancing their collective research efforts in the pharmaceutical domain.

Conclusion

Jung Eun Park stands out as an inspiring inventor in the pharmaceutical industry. Her groundbreaking patent on acid secretion inhibition demonstrates her innovative spirit and dedication to improving healthcare. With her continued efforts and collaborations, she is likely to contribute even more to the world of pharmaceuticals in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…